array:19 [ "pii" => "S2173574324001114" "issn" => "21735743" "doi" => "10.1016/j.reumae.2024.09.002" "estado" => "S300" "fechaPublicacion" => "2024-10-01" "aid" => "1773" "copyright" => "Sociedad Española de Reumatología (SER), Colegio Mexicano de Reumatología (CMR) and Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2024;20:423-39" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Special Article</span>" "titulo" => "Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "423" "paginaFinal" => "439" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 4073 "Ancho" => 2458 "Tamanyo" => 732442 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0070" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Rheumatoid arthritis treatment algorithm.</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">DMARD: disease-modifying drug. B: biologic. CS: Conventional synthetic. AMO: Another mechanism of action.</p> <p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">JAKi: Janus kinase inhibitor*: Limit the use of JAKi in patients of 65 years and over; those with risk factors for cardiovascular or thromboembolic disease; smokers; or those with additional risk factors for cancer.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José María Álvaro-Gracia Álvaro, Petra Díaz del Campo Fontecha, José Luis Andréu Sánchez, Alejandro Balsa Criado, Rafael Cáliz Cáliz, Isabel Castrejón Fernández, Hèctor Corominas, José A. Gómez Puerta, Sara Manrique Arija, Natalia Mena Vázquez, Ana Ortiz García, Chamaida Plasencia Rodríguez, Lucía Silva Fernández, Jesús Tornero Molina" "autores" => array:14 [ 0 => array:2 [ "nombre" => "José María" "apellidos" => "Álvaro-Gracia Álvaro" ] 1 => array:2 [ "nombre" => "Petra" "apellidos" => "Díaz del Campo Fontecha" ] 2 => array:2 [ "nombre" => "José Luis" "apellidos" => "Andréu Sánchez" ] 3 => array:2 [ "nombre" => "Alejandro" "apellidos" => "Balsa Criado" ] 4 => array:2 [ "nombre" => "Rafael" "apellidos" => "Cáliz Cáliz" ] 5 => array:2 [ "nombre" => "Isabel" "apellidos" => "Castrejón Fernández" ] 6 => array:2 [ "nombre" => "Hèctor" "apellidos" => "Corominas" ] 7 => array:2 [ "nombre" => "José A." "apellidos" => "Gómez Puerta" ] 8 => array:2 [ "nombre" => "Sara" "apellidos" => "Manrique Arija" ] 9 => array:2 [ "nombre" => "Natalia" "apellidos" => "Mena Vázquez" ] 10 => array:2 [ "nombre" => "Ana" "apellidos" => "Ortiz García" ] 11 => array:2 [ "nombre" => "Chamaida" "apellidos" => "Plasencia Rodríguez" ] 12 => array:2 [ "nombre" => "Lucía" "apellidos" => "Silva Fernández" ] 13 => array:2 [ "nombre" => "Jesús" "apellidos" => "Tornero Molina" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X24000676" "doi" => "10.1016/j.reuma.2024.05.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X24000676?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574324001114?idApp=UINPBA00004M" "url" => "/21735743/0000002000000008/v1_202410110607/S2173574324001114/v1_202410110607/en/main.assets" ]
Journal Information
Vol. 20. Issue 8.
Pages 423-439 (October 2024)
Vol. 20. Issue 8.
Pages 423-439 (October 2024)
Special Article
Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis
Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide
José María Álvaro-Gracia Álvaro, Petra Díaz del Campo Fontecha, José Luis Andréu Sánchez, Alejandro Balsa Criado, Rafael Cáliz Cáliz, Isabel Castrejón Fernández, Hèctor Corominas, José A. Gómez Puerta, Sara Manrique Arija, Natalia Mena Vázquez, Ana Ortiz García, Chamaida Plasencia Rodríguez, Lucía Silva Fernández, Jesús Tornero Molina
Article information
These are the options to access the full texts of the publication Reumatología Clínica (English Edition)